Department of Radiation Oncology
Gynecologic Oncology (Including Cervical Cancer, Endometrial Cancer)

Equipment Advantages

• 1
  The latest generation GE Discovery MI PET/CT and NM/CT 870 SPECT/CT systems in China: Achieve comprehensive coverage from molecular imaging diagnosis of genitourinary system tumors to routine assessments such as split renal function (GFR) evaluation. In particular, the application of the novel molecular probe 18F-PSMA (Prostate-Specific Membrane Antigen ligand) provides new means for the early diagnosis, initial staging, biochemical recurrence and efficacy evaluation of prostate cancer, as well as the assessment of tumor heterogeneity and biological behavior.
• 2
  The world's most advanced Hitachi proton and heavy ion integrated radiotherapy system: Utilizes internationally leading proton and heavy ion technologies. Proton and heavy ion therapy possesses a unique "Bragg Peak" effect, enabling precise delivery of radiation energy to the tumor tissue, thereby significantly minimizing damage to normal tissues. It is particularly suitable for pediatric tumors, head and neck tumors, brain tumors, hepatobiliary and pancreatic tumors, and patients with poor radiotherapy tolerance.
• 3
  Varian TrueBEAM with HyperArc: The Varian TrueBEAM linear accelerator features HyperArc technology, enabling ultra-high precision stereotactic body radiation therapy (SBRT/SRS). HyperArc technology can precisely treat multiple tumor lesions in a single session within an extremely short time, especially suitable for patients with brain metastases. It significantly improves tumor control rates, reduces the number of treatment sessions, and enhances the patient treatment experience.
• 4
  Adaptive Radiotherapy (Adaptive RT): Employs cutting-edge adaptive radiotherapy technology, allowing real-time adjustment of the treatment plan throughout the radiotherapy process based on changes in tumor morphology and position. Through real-time imaging monitoring and precise dynamic adjustments, it effectively enhances treatment outcomes, maximizes the protection of normal tissues, and ensures that each patient receives the most precise and safest treatment experience.